Pharmacokinetic and pharmacodynamic evaluation of the novel CCR1 antagonist CCX354 in healthy human subjects: implications for selection of clinical dose.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples